Cor Vasa 2010, 52(3):116-120 | DOI: 10.33678/cor.2010.035

Multiple organ dysfunction syndrome: update 2010

Jiří Chvojka, Martin Matějovič*
I. interní klinika, JIP, Lékařská fakulta v Plzni, Univerzita Karlova v Praze a Fakultní nemocnice Plzeň, česká republika

Multiple organ dysfunction syndrome (MODS) is the leading cause of death in intensive care units. Critically ill patients may develop MODS during the course of severe infections, shock, multiple trauma, massive hemorrhage or a combination of the above. Although the exact pathophysiology of MODS remains unknown, it involves widespread molecular, cellular, and systemic alterations characterized by deregulated inflammatory processes, activation of coagulation, neuroendocrine and metabolic responses. Early and aggressive treatment of the underlying disease remains the cornerstone of MODS prevention, while the treatment of MODS itself remains primarily supportive. This review summarizes the epidemiology of MODS, briefly describes our current understanding of the pathophysiology, and discusses the basic principles of preventive and therapeutic approaches.

Keywords: Multiple organ dysfunction; Sepsis; Shock; Pathophysiology; treatment; Intensive care; Organ support

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chvojka J, Matějovič M. Multiple organ dysfunction syndrome: update 2010. Cor Vasa. 2010;52(3):116-120. doi: 10.33678/cor.2010.035.
Download citation

References

  1. Baue AE. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg 1975;110:779-781. Go to original source... Go to PubMed...
  2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864.
  3. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006;34:344-355. Go to original source... Go to PubMed...
  4. Rivers EP, Kruse JA, Jacobsen G, et al. The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. Crit Care Med 2007;35:2016-2024. Go to original source... Go to PubMed...
  5. Vincent JL, De Backer D. Microvascular dysfunction as a cause of organ dysfunction in severe sepsis. Crit Care 2005;9(Suppl 4):S9-S12. Go to original source... Go to PubMed...
  6. Sakr Y, Dubios MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32:1825-1831. Go to original source... Go to PubMed...
  7. Trzeciak S, McCoy JV, Phillip Dellinger R, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34:2210-2217. Go to original source... Go to PubMed...
  8. Jhanji S, Lee C, Watson D, et al. Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications. Intensive Care Med 2009;35:671-677. Go to original source... Go to PubMed...
  9. Levy RJ. Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 2007;28:24-28. Go to original source... Go to PubMed...
  10. Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004;364:545. Go to original source... Go to PubMed...
  11. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219. Go to original source... Go to PubMed...
  12. Hauser B, Bracht H, Matejovic M, et al. Nitric oxide synthase inhibition in sepsis? Lessons learned from large-animal studies. Anesth Analg 2005; 101:488-498. Go to original source... Go to PubMed...
  13. Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med 2004;30:1032-1040. Go to original source... Go to PubMed...
  14. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006;6:813. Go to original source... Go to PubMed...
  15. Sutherland AM, Walley KR. Bench-to-bedside review: Association of genetic variation with sepsis. Crit Care 2009;13:210.
  16. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008;34:17-60. Go to original source... Go to PubMed...
  17. Ranieri VM, Giunta F, Suter PM, et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 2000;284:43. Go to original source... Go to PubMed...
  18. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342:1301.
  19. Villar J, Kacmarek RM, Pérez-Méndez L, et al. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial. Crit Care Med 2006;34:1311. Go to original source... Go to PubMed...
  20. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;53:961-973. Go to original source... Go to PubMed...
  21. Damman K, van Deursen VM, Navis G, et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009;53:582-588. Go to original source... Go to PubMed...
  22. Chvojka J, Sykora R, Krouzecky A, et al. Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs. Crit Care 2008;12:R164. Go to original source... Go to PubMed...
  23. Venkataraman R. Can we prevent acute kidney injury? Crit Care Med 2008;36:S166-S171. Go to original source... Go to PubMed...
  24. Sýkora R, Chvojka J, Kroužecký A, et al. Hemoeliminační metody v léčbě sepse: současný stav. Vnitř Lék 2008;54:1000-1005. Go to PubMed...
  25. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-1596. Go to original source... Go to PubMed...
  26. Ronco C, Davenport A, Gura V. A wearable artificial kidney: dream or reality? Nat Clin Pract Nephrol 2008;4:604-605. Go to original source... Go to PubMed...
  27. Okamoto E, Makino T, Tanaka S, et al. Development of a miniature motor-driven pulsatile LVAD driven by a fuzzy controller. J Artif Organs 2007; 10:158-164. Go to original source... Go to PubMed...
  28. Cattaneo G, Strauss A, Reul H. Compact intra- and extracorporeal oxygenator developments. Perfusion 2004;19:251-255. Go to original source... Go to PubMed...
  29. Fissell WH, Humes HD, Fleischman AJ, et al. Dialysis and nanotechnology: Now, 10 years, or never? Blood Purif 2007;25:12-17. Go to original source... Go to PubMed...
  30. Handley HH, Gorsuch R, Peters H, et al. Slow continuous intravenous plasmapheresis (SCIP): Clinical applications and hemostability of extracorporeal ultrafiltration. Contrib Nephrol 2005;149:334-342. Go to original source... Go to PubMed...
  31. Handley HH, Ronco F, Gorsuch R, et al. Artificial in vivo biofiltration: slow continuous intravenous plasmafiltration (SCIP) and artificial organ support Int J Artif Organs 2004;27:186-194. Go to original source... Go to PubMed...
  32. Ding F, Humes HD. The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol 2008;109:e118-e122. Go to original source... Go to PubMed...
  33. McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis 2008;28:210-217. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.